Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
59717-9 Nordiazepam MCnc Bld Pt Qn Confirm   ACTIVE Nordiazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59717-9   Confirm     Both       0 Nordiazepam Bld Cfm-mCnc       N   Blood; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan; WB; Whole blood 2.73 2.32               ng/mL       0
59718-7 Nordiazepam MCnc Body fld Pt Qn     ACTIVE Nordiazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59718-7         Both       0 Nordiazepam Fld-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan 2.7 2.32               ng/mL       0
59719-5 Nordiazepam MCnc Body fld Pt Qn Confirm   ACTIVE Nordiazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59719-5   Confirm     Both       0 Nordiazepam Fld Cfm-mCnc       N   B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; LC/MS/MS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan 2.7 2.32               ng/mL       0
5972-5 Plasminogen activator tissue type Ag^20M post venistasis MCnc PPP Pt Qn IA   ACTIVE Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasis   MAJ DefinitionDescription                   COAG   5972-5   IA     Both       0 tPA Ag 20M PPP IA-mCnc       Y   After; Antigen; Antigens; Blood plasminogen activator; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Plas; Platelet poor plasma; PLG; PLGN; Point in time; Profibrinolysin; PST; QNT; Quan; Quant; Quantitative; Random; SUDS; Tissue plasminogen activator; TPA; t-PA; Vascular plasminogen activator 2.58 1.0d                     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59720-3 Nordiazepam MCnt Meconium Pt Qn Confirm   ACTIVE Nordiazepam [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59720-3   Confirm     Both       0 Nordiazepam Mec Cfm-mCnt       N   Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Madar; Mass content; Mec; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tranxilium N; Vegesan 2.7 2.32               ng/g       0
59721-1 Nordiazepam MCnc Ser/Plas Pt Qn Confirm   ACTIVE Nordiazepam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59721-1   Confirm     Both       0 Nordiazepam SerPl Cfm-mCnc       N   Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Madar; Mass concentration; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Pl; Plasma; Plsm; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stilny; Tranxilium N; Vegesan 2.73 2.32               ng/mL       0
59722-9 Nordiazepam MCnt Stool Pt Qn Confirm   ACTIVE Nordiazepam [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59722-9   Confirm     Both       0 Nordiazepam Stl Cfm-mCnt       N   Bowel movement; Calmday; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; LC/MS/MS; Madar; Mass content; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Stl; Stool = Fecal; Tranxilium N; Vegesan 2.7 2.32               ng/g       0
59723-7 Nordiazepam MCnt Tiss Pt Qn     ACTIVE Nordiazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59723-7         Both       0 Nordiazepam Tiss-mCnt       N   Calmday; Chlordiazepoxide metabolite; Desmethyldiazepam; Diazepam metabolite; Dimethyldiazepam; DRUG/TOXICOLOGY; Drugs; Madar; Mass content; n-dimethyldiazepam; Nordaz; Nordazepam; Nordiaze; Point in time; Praxadium; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Stilny; Tissue; Tissue, unspecified; Tranxilium N; Vegesan 2.7 2.32               ng/g       0
59724-5 Cathine MCnc Ser/Plas Pt Qn     ACTIVE Cathine [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ng/mL 5 ng/mL           DRUG/TOX   59724-5         Both       0 Cathine SerPl-mCnc       N   Addiction; d-Norpseudoephedrine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Norpseudoephedrine; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32               ng/mL       0
59725-2 Oxazepam MCnc Bld Pt Qn     ACTIVE Oxazepam [Mass/volume] in Blood   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59725-2         Both       0 Oxazepam Bld-mCnc       N   Alepam; Blood; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; WB; Whole blood 2.7 2.32               ng/mL       0
59726-0 Oxazepam MCnc Bld Pt Qn Confirm   ACTIVE Oxazepam [Mass/volume] in Blood by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59726-0   Confirm     Both       0 Oxazepam Bld Cfm-mCnc       N   Alepam; Blood; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; WB; Whole blood 2.73 2.32               ng/mL       0
59727-8 Oxazepam MCnc Body fld Pt Qn     ACTIVE Oxazepam [Mass/volume] in Body fluid   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59727-8         Both       0 Oxazepam Fld-mCnc       N   Alepam; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite 2.7 2.32               ng/mL       0
59728-6 Oxazepam MCnc Body fld Pt Qn Confirm   ACTIVE Oxazepam [Mass/volume] in Body fluid by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59728-6   Confirm     Both       0 Oxazepam Fld Cfm-mCnc       N   Alepam; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; GCMS; LC/MS/MS; Level; Mass concentration; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite 2.7 2.32               ng/mL       0
59729-4 Oxazepam MCnt Meconium Pt Qn Confirm   ACTIVE Oxazepam [Mass/mass] in Meconium by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59729-4   Confirm     Both       0 Oxazepam Mec Cfm-mCnt       N   Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mass content; Mec; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite 2.7 2.32               ng/g       0
5973-3 Plasminogen activator tissue type Ag^10M post venistasis MCnc PPP Pt Qn IA   ACTIVE Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasis   MIN DefinitionDescription                   COAG   5973-3   IA     Both       0 tPA Ag 10M PPP IA-mCnc       Y   After; Antigen; Antigens; Blood plasminogen activator; COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; Hematology; Heme; IAA; Level; Mass concentration; MEIA; Plas; Platelet poor plasma; PLG; PLGN; Point in time; Profibrinolysin; PST; QNT; Quan; Quant; Quantitative; Random; SUDS; Tissue plasminogen activator; TPA; t-PA; Vascular plasminogen activator 2.73 1.0d                     Renamed Method from "Imm" to "IA" for consistency across classes (approved by Laboratory LOINC Committee 2016 12). 0
59730-2 Oxazepam MCnc Ser/Plas Pt Qn Confirm   ACTIVE Oxazepam [Mass/volume] in Serum or Plasma by Confirmatory method   MIN DefinitionDescription     ng/mL 20 ng/mL           DRUG/TOX   59730-2   Confirm     Both       0 Oxazepam SerPl Cfm-mCnc       N   Alepam; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Temazepam metabolite 2.73 2.32               ng/mL       0
59731-0 Oxazepam MCnt Stool Pt Qn Confirm   ACTIVE Oxazepam [Mass/mass] in Stool by Confirmatory method   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59731-0   Confirm     Both       0 Oxazepam Stl Cfm-mCnt       N   Alepam; Bowel movement; Cfm; Chlordiazepoxide metabolite; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Faecal; Faeces; Fecal; Feces; GCMS; LC/MS/MS; Mass content; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Stl; Stool = Fecal; Temazepam metabolite 2.7 2.32               ng/g       0
59732-8 Oxazepam MCnt Tiss Pt Qn     ACTIVE Oxazepam [Mass/mass] in Tissue   MIN DefinitionDescription     ng/g 20 ng/g           DRUG/TOX   59732-8         Both       0 Oxazepam Tiss-mCnt       N   Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Mass content; Point in time; Prazepam metabolite; QNT; Quan; Quant; Quantitative; Random; Serax; Temazepam metabolite; Tissue; Tissue, unspecified 2.7 2.32               ng/g       0
59733-6 Potassium MCnt Tiss Pt Qn     ACTIVE Potassium [Mass/mass] in Tissue   MIN DefinitionDescription     mEq/g 1 mEq/g           DRUG/TOX   59733-6         Both       0 Potassium Tiss-mCnt       N   DRUG/TOXICOLOGY; Drugs; k; K+; Mass content; Point in time; Potass; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified 2.7 2.32               meq/g       0
59734-4 Propoxyphene PrThr Ser/Plas Pt Ord Screen   ACTIVE Propoxyphene [Presence] in Serum or Plasma by Screen method   MIN DefinitionDescription       50 ng/mL           DRUG/TOX   59734-4   Screen     Both       0 Propoxyph SerPl Ql Scn       N   Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.32                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
59735-1 Salicylamide MCnc Bld Pt Qn     ACTIVE Salicylamide [Mass/volume] in Blood   MIN DefinitionDescription     ug/mL 2 mcg/mL           DRUG/TOX   59735-1         Both       0 Salicylamide Bld-mCnc       N   Blood; DRUG/TOXICOLOGY; Drugs; Level; Lobac; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salicylamid; Sinedol; Triaprin-DC; Utrosal; WB; Whole blood 2.7 2.32               ug/mL       0
59736-9 Salicylamide MCnc Urine Pt Qn     ACTIVE Salicylamide [Mass/volume] in Urine   MIN DefinitionDescription     ug/mL 2 mcg/mL           DRUG/TOX   59736-9         Both       0 Salicylamide Ur-mCnc       N   DRUG/TOXICOLOGY; Drugs; Level; Lobac; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Salicylamid; Sinedol; Triaprin-DC; UA; UR; Urn; Utrosal 2.7 2.32               ug/mL       0
59737-7 Selenium MCnt Nail Pt Qn     ACTIVE Selenium [Mass/mass] in Nail   MIN DefinitionDescription     ug/g 10 mcg/g           DRUG/TOX   59737-7         Both       0 Selenium Nail-mCnt       N   DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; SE; Ungal nail 2.7 2.32               ug/g       0
59738-5 Silver MCnc Body fld Pt Qn     ACTIVE Silver [Mass/volume] in Body fluid   MIN DefinitionDescription     ug/L 0.5 mcg/L           DRUG/TOX   59738-5         Both       0 Silver Fld-mCnc       N   Ag; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv 2.7 2.32               ug/L       0
59739-3 Silver MCnt Nail Pt Qn     ACTIVE Silver [Mass/mass] in Nail   MIN DefinitionDescription     ug/g 0.5 mcg/g           DRUG/TOX   59739-3         Both       0 Silver Nail-mCnt       N   Ag; DRUG/TOXICOLOGY; Drugs; Mass content; Nails; Point in time; QNT; Quan; Quant; Quantitative; Random; Silv; Ungal nail 2.7 2.32               ug/g       0
104,672 results found